entity

Mitochondrial DNA Release

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Mitochondrial DNA Release: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

73Connections

2Hypotheses

4Analyses

37Outgoing

36Incoming

10Experiments

4Debates

No AI portrait yet

Outgoing (37)

Target	Relation	Type	Str
CGAS	activates	protein	0.95
cGAS/STING	activates	unknown	0.95
neuronal PANoptosis	causes	unknown	0.95
innate immune responses	activates	unknown	0.95
AIM2_inflammasome	activates	unknown	0.92
cGAS-STING pathway	activates	pathway	0.90
cGAS-STING signaling	activates	pathway	0.90
neurodegeneration	causes	disease	0.90
cognitive decline	contributes_to	disease	0.90
neuroinflammation	mediates	mechanism	0.90
neuroinflammation	causes	mechanism	0.90
cGAS-STING signaling activation	activates	unknown	0.90
innate immune signaling	activates	unknown	0.90
NF-κB	activates	unknown	0.90
neuroinflammation	contributes_to	mechanism	0.90
cGAS-STING Pathway	activates	pathway	0.85
neurodegeneration	contributes_to	disease	0.85
necroptosis	contributes_to	unknown	0.85
mitochondrial_dysfunction	associated_with	mechanism	0.85
alzheimer_disease	biomarker_for	disease	0.85
microglial_activation	activates	mechanism	0.80
microglial activation	causes	mechanism	0.80
microglial activation	activates	mechanism	0.80
microglial activation	contributes_to	mechanism	0.80
mitochondrial transfer	associated_with	mechanism	0.80
mitochondrial dysfunction	associated_with	mechanism	0.80
oxidative stress	associated_with	mechanism	0.80
Innate Immune Activation	contributes_to	process	0.80
phagocytosis	activates	mechanism	0.75
oxidative stress	contributes_to	mechanism	0.75
alzheimers	implicated_in	disease	0.70
phagocytosis	associated_with	mechanism	0.70
phagocytosis	involved_in	mechanism	0.70
glymphatic_clearance	associated_with	mechanism	0.70
glymphatic_clearance	modulates	mechanism	0.70
mitochondrial_transfer	associated_with	mechanism	0.70
glymphatic clearance	associated_with	mechanism	0.65

Incoming (36)

Source	Relation	Type	Str
TDP-43	associated_with	protein	0.95
mitochondrial quality control failure	causes	unknown	0.95
sleep deprivation	causes	mechanism	0.95
proteasome dysfunction	causes	unknown	0.95
mitochondrial dysfunction	associated_with	mechanism	0.90
lipid peroxidation products	contributes_to	mechanism	0.90
oxidative stress	causes	mechanism	0.90
mitochondrial dysfunction	causes	mechanism	0.90
microglial activation	mediates	mechanism	0.90
TDP43	associated_with	protein	0.90
mitochondrial damage	causes	phenotype	0.90
MPTP	mediates	protein	0.90
microglial_activation	causes	mechanism	0.88
microglial activation	causes	mechanism	0.85
ALOX15	contributes_to	gene	0.85
oxidative stress	contributes_to	mechanism	0.85
stress deprivation	causes	unknown	0.85
mitochondrial dysfunction	contributes_to	mechanism	0.85
TDP-43 aggregation	associated_with	mechanism	0.85
microglial activation	associated_with	mechanism	0.85
MFN2	regulates	gene	0.85
mitochondrial_dysfunction	associated_with	mechanism	0.82
loss of metabolic flexibility	associated_with	unknown	0.80
GCase	contributes_to	protein	0.80
melatonin	inhibits	drug	0.80
oxidative stress	associated_with	mechanism	0.78
lipid peroxidation products	associated_with	mechanism	0.75
HSP70	inhibits	protein	0.75
PIEZO1 activation	contributes_to	mechanism	0.75
cGAS signaling	mediates	unknown	0.72
phagocytosis	involved_in	mechanism	0.70
senescent glial cells	causes	cell_type	0.70
mitochondrial transfer	associated_with	mechanism	0.70
TFEB	modulates	protein	0.70
HSP70	modulates	protein	0.68
TFAM	modulates	protein	0.65

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Senescent Cell Mitochondrial DNA Release	0.742	neurodegeneration	Senolytic therapy for age-related neurod
Mitochondrial DNA Release-STING Axis as Senolytic Efficacy P	0.380	molecular biology	What is the optimal therapeutic window t

Mentioning Analyses (4)

Scientific analyses that reference this entity

What upstream mechanisms cause TDP-43 to trigger mPTP opening and can this be th

neurodegeneration | 2026-04-08 | 5 hypotheses Top: 0.693

How does chronic cGAS/STING activation downstream of TDP-43 contribute to progre

neuroinflammation | 2026-04-07 | 8 hypotheses Top: 0.771

What determines the specificity of TDP-43-induced mitochondrial DNA release for

neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.720

Senolytic therapy for age-related neurodegeneration

neurodegeneration | 2026-04-01 | 0 hypotheses

Experiments (10)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
iPSC-derived astrocyte-neuron co-culture mitochondrial transfer in PD	exploratory	Parkinson's disease	0.900	0.00	iPSC-derived dopaminergic neur	proposed	N/A
Proposed experiment from debate on Senolytics targeting p16/p21+ senes	falsification	Neurodegeneration	0.400	0.50	cell_line	proposed	$80,000
Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe	clinical	Neurodegeneration	0.400	0.50	in_silico	proposed	$180,000
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts	clinical	ALS	0.400	0.50	human	proposed	$6,550,000
cGAS-STING Pathway Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$7,100,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$5,460,000
Regulated Necrosis Validation Study in Parkinson's Disease	clinical	Parkinson's Disease	0.400	0.50	human	proposed	$6,550,000
Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
Traumatic Brain Injury and Alzheimer's Disease Relationship	validation	Alzheimer's Disease	0.400	0.50	human	proposed	$3,000,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745]	Yu CH, Davidson S, Harapas CR, Hilton JB	Cell	2020	2
Past, present and future perspectives on the science of aging. [PMID:41566049]	Fabrisia Ambrosio; Maxim N Artyomov; Ste	Nature aging	2026	0
Stimuli-responsive nanoplatforms for precision activation of the STING pathway i [PMID:41668757]	["Bi D", "Yang X", "Wang Y", "Yong J", "	Frontiers in immunology	2026	0
Decoding senescent drivers in Alzheimer's disease: From bench to bedside. [PMID:41344577]	["Zhou R", "Lin X", "Liao Z", "Lin J", "	Ageing research reviews	2026	0
Role of NEIL1 in genome maintenance. [PMID:40010204]	["McCullough A", "Minko I", "Luzadder M"	DNA repair	2025	0
Bionanoconjugates in Neurodegeneration: Peptide-Nanoparticle Alliances for Next- [PMID:41199078]	["Ranjitha V", "Kumar A", "Kaalappa P"]	Pharmaceutical research	2025	0
Mitochondrial DNA released by senescent tumor cells enhances PMN-MDSC-driven imm [PMID:40203808]	["Lai P", "Liu L", "Bancaro N", "Troiani	Immunity	2025	0
Apheresis for senescence: Targeting the senescence-associated secretory phenotyp [PMID:40651559]	["Akgun Y"]	Ageing research reviews	2025	0
Methodological influences on circulating cell-free-mitochondrial and nuclear DNA [PMID:40080226]	["Daubermann C", "Herhaus B", "Neuberger	Molecular biology reports	2025	0
Innate immune sensing of Z-nucleic acids by ZBP1-RIPK1 axis drives neuroinflamma [PMID:40902587]	["Song Z", "Xie X", "Chen Y", "Zhang B",	Immunity	2025	0
Exosomes as nanocarriers for brain-targeted delivery of therapeutic nucleic acid [PMID:40533746]	["Sanadgol N", "Abedi M", "Hashemzaei M"	Journal of nanobiotechnology	2025	0
Antileukemic potential of methylated indolequinone MAC681 through immunogenic ne [PMID:38704604]	["Orlikova-Boyer B", "Lorant A", "Gajula	Biomarker research	2024	0
Enhancing Radiofrequency Ablation for Hepatocellular Carcinoma: Nano-Epidrug Eff [PMID:39548919]	["Li X", "Liu Y", "Ke J", "Wang Z", "Han	Advanced materials (Deerfield	2024	0
The cGAS-STING pathway drives neuroinflammation and neurodegeneration via cellul [PMID:39490400]	Zhang Y, Zou M, Wu H, Zhu J, Jin T	Neurobiology of disease	2024	0
mtDNA release promotes cGAS-STING activation and accelerated aging of postmitoti [PMID:39039044]	["Li Y", "Cui J", "Liu L", "Hambright W"	Cell death & disease	2024	0
Senescent glia link mitochondrial dysfunction and lipid accumulation. [PMID:38839958]	["Byrns C", "Perlegos A", "Miller K", "J	Nature	2024	0
Apoptotic stress causes mtDNA release during senescence and drives the SASP. [PMID:37821702]	["Victorelli S", "Salmonowicz H", "Chapm	Nature	2023	0
Exposome and unhealthy aging: environmental drivers from air pollution to occupa [PMID:37688657]	Pandics T, Major D, Fazekas-Pongor V, Sz	GeroScience	2023	0
cGAS-STING drives ageing-related inflammation and neurodegeneration. [PMID:37532932]	Gulen MF, Samson N, Keller A, Schwabenla	Nature	2023	0
Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STI [PMID:36964253]	["Kim J", "Kim H", "Chung J"]	Experimental & molecular medic	2023	0

Debates (4)

Multi-agent debates referencing this entity

While the study establishes TDP-43 triggers mtDNA release via mPTP to activate c

closed · Rounds: 4 · Score: 0.73 · 2026-04-21

The study identifies cGAS/STING activation as a consequence of TDP-43-mediated m

closed · Rounds: 4 · Score: 0.73 · 2026-04-21

While the study demonstrates TDP-43 triggers mPTP-mediated mtDNA release, the mo

closed · Rounds: 4 · Score: 0.77 · 2026-04-21

What are the mechanisms underlying senolytic therapy for age-related neurodegene

closed · Rounds: 4 · Score: 0.92 · 2026-04-01

Related Research

Hypotheses and analyses mentioning Mitochondrial DNA Release in their description or question text

No additional research found